Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Cancer
Published in: Molecular Cancer 1/2010

Open Access 01-12-2010 | Research

Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry

Authors: Ying Liu, Yanfeng Chen, Amin Momin, Rebecca Shaner, Elaine Wang, Nathan J Bowen, Lilya V Matyunina, L DeEtte Walker, John F McDonald, M Cameron Sullards, Alfred H Merrill Jr

Published in: Molecular Cancer | Issue 1/2010

Login to get access

Abstract

Background

Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms.

Results

Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(m/z 885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of GalCer synthase and Gal3ST1 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST.

Conclusions

This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers.
Appendix
Available only for authorised users
Literature
1.
Warrenfeltz S, Pavlik S, Datta S, Kraemer ET, Benigno B, McDonald JF: Gene expression profiling of epithelial ovarian tumours correlated with malignant potential. Mol Cancer. 2004, 3: 27- 10.1186/1476-4598-3-27PubMedCentralCrossRefPubMed
2.
Schwartz PE: Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res. 2002, 107: 99-118.PubMed
3.
4.
5.
Morichika H, Hamanaka Y, Tai T, Ishizuka I: Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer. 1996, 78: 43-47. 10.1002/(SICI)1097-0142(19960701)78:1<43::AID-CNCR8>3.0.CO;2-ICrossRefPubMed
6.
Hiraiwa N, Fukuda Y, Imura H, Tadano-Aritomi K, Nagai K, Ishizuka I, Kannagi R: Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies. Cancer Res. 1990, 50: 2917-2928.PubMed
7.
Sakakibara N, Gasa S, Kamio K, Makita A, Nonomura K, Togashi M, Koyanagi T, Hatae Y, Takeda K: Distinctive glycolipid patterns in Wilms' tumor and renal cell carcinoma. Cancer Lett. 1991, 57: 187-192. 10.1016/0304-3835(91)90155-BCrossRefPubMed
8.
Gnewuch C, Jaques G, Havemann K, Wiegandt H: Re-assessment of acidic glycosphingolipids in small-cell-lung-cancer tissues and cell lines. Int J Cancer Suppl. 1994, 8: 125-126. 10.1002/ijc.2910570727CrossRefPubMed
9.
Makhlouf AM, Fathalla MM, Zakhary MA, Makarem MH: Sulfatides in ovarian tumors: clinicopathological correlates. Int J Gynecol Cancer. 2004, 14: 89-93. 10.1111/j.1048-891x.2004.014223.x-1CrossRefPubMed
10.
Kean EL: Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides. J Lipid Res. 1968, 9: 319-327.PubMed
11.
Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, McDonald JF: Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics. 2009, 2: 71- 10.1186/1755-8794-2-71PubMedCentralCrossRefPubMed
12.
Shaner RL, Allegood JC, Park H, Wang E, Kelly S, Haynes CA, Sullards MC, Merrill AH: Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res. 2009, 50: 1692-1707. 10.1194/jlr.D800051-JLR200PubMedCentralCrossRefPubMed
13.
Chen Y, Allegood J, Liu Y, Wang E, Cachon-Gonzalez B, Cox TM, Merrill AH, Sullards MC: Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. Anal Chem. 2008, 80: 2780-2788. 10.1021/ac702350gCrossRefPubMed
14.
15.
Merrill AH, Stokes TH, Momin A, Park H, Portz BJ, Kelly S, Wang E, Sullards MC, Wang MD: Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res. 2009, 50 (Suppl): S97-102. 10.1194/jlr.R800073-JLR200PubMedCentralPubMed
16.
Riebeling C, Allegood JC, Wang E, Merrill AH, Futerman AH: Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem. 2003, 278: 43452-43459. 10.1074/jbc.M307104200CrossRefPubMed
17.
Hornemann T, Penno A, Rutti MF, Ernst D, Kivrak-Pfiffner F, Rohrer L, von Eckardstein A: The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J Biol Chem. 2009, 284: 26322-26330. 10.1074/jbc.M109.023192PubMedCentralCrossRefPubMed
18.
Enomoto A, Omae F, Miyazaki M, Kozutsumi Y, Yubisui T, Suzuki A: Dihydroceramide:sphinganine C-4-hydroxylation requires Des2 hydroxylase and the membrane form of cytochrome b5. Biochem J. 2006, 397: 289-295. 10.1042/BJ20051938PubMedCentralCrossRefPubMed
19.
Cornett DS, Reyzer ML, Chaurand P, Caprioli RM: MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods. 2007, 4: 828-833. 10.1038/nmeth1094CrossRefPubMed
20.
Jackson SN, Wang HY, Woods AS: In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS. J Am Soc Mass Spectrom. 2007, 18: 17-26. 10.1016/j.jasms.2006.08.015CrossRefPubMed
21.
Hsu FF, Turk J: Studies on sulfatides by quadrupole ion-trap mass spectrometry with electrospray ionization: structural characterization and the fragmentation processes that include an unusual internal galactose residue loss and the classical charge-remote fragmentation. J Am Soc Mass Spectrom. 2004, 15: 536-546. 10.1016/j.jasms.2003.12.007CrossRefPubMed
22.
Marbois BN, Faull KF, Fluharty AL, Raval-Fernandes S, Rome LH: Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. Biochim Biophys Acta. 2000, 1484: 59-70.CrossRefPubMed
23.
Burnum KE, Cornett DS, Puolitaival SM, Milne SB, Myers DS, Tranguch S, Brown HA, Dey SK, Caprioli RM: Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J Lipid Res. 2009,
24.
Kiguchi KT, Takamatsu K, Tanaka J, Nozawa S, Iwamori M, Nagai Y: Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and Lewis antigen in mucinous cystadenocarcinoma. Cancer Research. 1992, 52: 416-421.PubMed
25.
Harris JF, Beaton DW: Sulfated glycoconjugate determinants recognized by monoclonal antibody, SG-1, correlate with the experimental metastatic ability of KHT fibrosarcoma cells. Clin Exp Metastasis. 1990, 8: 361-379. 10.1007/BF01810681CrossRefPubMed
26.
Garcia J, Callewaert N, Borsig L: P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology. 2007, 17: 185-196. 10.1093/glycob/cwl059CrossRefPubMed
27.
Shikata K, Suzuki Y, Wada J, Hirata K, Matsuda M, Kawashima H, Suzuki T, Iizuka M, Makino H, Miyasaka M: L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction. J Pathol. 1999, 188: 93-99. 10.1002/(SICI)1096-9896(199905)188:1<93::AID-PATH305>3.0.CO;2-#CrossRefPubMed
28.
Popovic ZV, Sandhoff R, Sijmonsma TP, Kaden S, Jennemann R, Kiss E, Tone E, Autschbach F, Platt N, Malle E, Grone HJ: Sulfated glycosphingolipid as mediator of phagocytosis: SM4 s enhances apoptotic cell clearance and modulates macrophage activity. J Immunol. 2007, 179: 6770-6782.CrossRefPubMed
29.
Robinson-Smith TM, Isaacsohn I, Mercer CA, Zhou M, Van Rooijen N, Husseinzadeh N, McFarland-Mancini MM, Drew AF: Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res. 2007, 67: 5708-5716. 10.1158/0008-5472.CAN-06-4375CrossRefPubMed
30.
31.
32.
Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S: Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science. 2009, 325: 1254-1257. 10.1126/science.1176709PubMedCentralCrossRefPubMed
33.
Wang MD, Shin DM, Simons JW, Nie S: Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther. 2007, 7: 833-837. 10.1586/14737140.7.6.833CrossRefPubMed
34.
Groseclose MR, Massion PP, Chaurand P, Caprioli RM: High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics. 2008, 8: 3715-3724. 10.1002/pmic.200800495PubMedCentralCrossRefPubMed
35.
Li J, Pearl DK, Pfeiffer SE, Yates AJ: Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors. J Neurosci Res. 1994, 39: 148-158. 10.1002/jnr.490390205CrossRefPubMed
36.
Merrill AH, Sullards MC, Allegood JC, Kelly S, Wang E: Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods. 2005, 36: 207-224. 10.1016/j.ymeth.2005.01.009CrossRefPubMed
37.
Schwartz SA, Reyzer M, Caprioli RM: Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom. 2003, 38: 9-10.1002/jms.505.CrossRef
38.
Cornett DS, Mobley J, Dias EC, Andersson M, Arteaga CL, Sanders ME, Caprioli RM: A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics. 2006, 5: 9-CrossRef
39.
Astigarraga E, Barreda-Gomez G, Lombardero L, Fresnedo O, Castano F, Giralt MT, Ochoa B, Rodriguez-Puertas R, Fernandez JA: Profiling and imaging of lipids on brain and liver tissue by matrix-assisted laser desorption/ionization mass spectrometry using 2-mercaptobenzothiazole as a matrix. Anal Chem. 2008, 80: 9105-9114. 10.1021/ac801662nCrossRefPubMed
40.
Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR: GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet. 2002, 31: 19-20. 10.1038/ng0502-19CrossRefPubMed
Metadata
Title
Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
Authors
Ying Liu
Yanfeng Chen
Amin Momin
Rebecca Shaner
Elaine Wang
Nathan J Bowen
Lilya V Matyunina
L DeEtte Walker
John F McDonald
M Cameron Sullards
Alfred H Merrill Jr
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2010
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-9-186

Other articles of this Issue 1/2010

Molecular Cancer 1/2010 Go to the issue

Research

Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent

Research

MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network

Research

NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations

Research

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β

Research

Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells

Research

Uncoupled responses of Smad4-deficient cancer cells to TNFα result in secretion of monomeric laminin-γ2
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits